Sharechat Logo

Ryman Healthcare Limited (NZX: RYM) unaudited first half underlying profit of $95.9m

Friday 19th November 2021

Text too small?

Ryman Healthcare’s unaudited first half underlying profit rose 8.5% to $95.9 million, with demand for retirement living and aged care remaining strong despite the challenges of COVID-19.

Unaudited reported (IFRS) profit, which includes unrealised fair value gains on investment property, increased 32.5% to $281.5 million in the six months to September 30.

Shareholders will receive an interim dividend of 8.8 cents per share. The record date for entitlements is December 10, and the dividend will be paid on December 17, 2021.

Group Chief Executive Richard Umbers said the Delta strain of COVID-19 had resulted in lengthy lockdowns in Melbourne and Auckland during the first half, but Ryman villages remained in strong demand.

Total transacted sales rose 48% to $510 million in the first half. Only 1.2% of the retirement village portfolio was available for resale at September 30.

“When you consider the extent of the lockdowns in Auckland and Melbourne, which are our biggest markets, sales have been remarkably resilient," Mr Umbers said.

The gradual easing of COVID-19 restrictions in Victoria, changes to migration settings in New Zealand and high vaccination rates in both countries were welcome news.

Ryman started work on three new sites during the half at Takapuna in Auckland and Highett and Ringwood East in Melbourne, bringing total villages in construction to 15.

“After 20 months of living in a pandemic we’re used to adapting and doing things differently to keep everyone safe and maintain momentum at the same time. There’s pressure on all our resources but we have strong supply lines and relationships with contractors.

“We expect to see pent-up demand come through in the market as restrictions lift in the next few months and we are cautiously optimistic about the months ahead.

“Since joining Ryman I have been impressed by the commitment of the team to keeping everyone safe, and the extraordinary care they take. I’ve had a warm welcome and I’m looking forward to building on Ryman’s success on both sides of the Tasman."

Chair Dr David Kerr said the board has adjusted the dividend policy from 50% of underlying profit to a 30%-50% range.

“We have strong long-term growth plans and this change will enhance our ability to continue to deliver the Ryman experience to more communities."

Please see the links below for details

Ryman Healthcare Limited - Announcement Numbers - 30 September 2021

Ryman Healthcare Limited - Media Release and Key Statistics - 30 September 2021

Ryman Healthcare Limited - Distribution Notice - 30 September 2021

Ryman Healthcare Limited – Results Presentation – 30 September 2021

Source: Ryman Healthcare Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

GSH Appointment of new Chairman
Greenfern secures agreement to supply medicinal cannabis
Rua on track to export to Germany by year end
HMY SECURES ADDITIONAL NZ$215M FACILITY TO SUPPORT GROWTH
Seeka releases Sustainability Report
NZL - Completion of Retail Offer
28th June 2022 Morning Report
Green Cross Health Limited 2022 Annual Report / NOM
Me Today completes Rights Issue
Channel confirms timing of Board Chair succession